LTE₄

The leukotriene E₄ (LTE₄) receptor, now widely recognized as GPR99/OXGR1 and also referred to as CysLT₃, is a G protein-coupled receptor that mediates cellular responses to the cysteinyl leukotriene LTE₄, a bioactive lipid mediator involved in allergic and inflammatory reactions^[1][2]. Mechanistically, LTE₄-GPR99 signaling activates predominantly G_q-dependent pathways and can additionally engage G_i signaling, thereby regulating inflammatory responses in epithelial and immune cell populations^[2]. The receptor participates in key biological processes associated with type 2 inflammation, bronchoconstriction, eosinophil recruitment, vascular permeability, and airway mucosal responses, linking LTE₄ signaling to asthma and other allergic diseases^[2][3][4]. Disease relevance is supported by observations that LTE₄ levels increase in severe asthma and aspirin-exacerbated respiratory disease, while GPR99 expression in respiratory tissues contributes to inflammatory amplification^[2]. Compared with the related cysteinyl leukotriene receptors CysLT₁ and CysLT₂, which preferentially recognize LTC₄ and LTD₄, GPR99 displays a distinct functional preference for LTE₄ and exhibits substantial sequence divergence, supporting its classification as a separate receptor subtype within the cysteinyl leukotriene receptor family^[1][2][5]. For experimental applications, GPR99 serves as a useful model for investigating LTE₄-specific inflammatory signaling and for evaluating receptor-targeted therapeutic strategies in allergic disease research^[1][3].